Sisram Medical Ltd, an investment holding company headquartered in Caesarea, Israel, since its establishment in 2013, is engaged in the creation, production, and worldwide distribution of a broad spectrum of medical solutions. The company develops and markets energy-based aesthetic devices, minimally invasive therapeutic systems, non-energy-dependent equipment, and cosmeceuticals, reaching markets across Asia Pacific, Europe, North America, Latin America, the Middle East, and Africa. Its comprehensive range of products and treatments addresses numerous conditions, such as hair removal, skin revitalization, acne and scarring, body and facial sculpting, pigment and skin surface refinement, fat transfer procedures, injectable dermal fillers, skin tissue regeneration injectables, personal wellness items, cosmetic dental procedures, transdermal delivery methods, cellulite reduction, stretch mark amelioration, therapy for vascular and pigmented lesions, hydradermabrasion, non-surgical eyelid lifts (blepharoplasty), liposuction, as well as feminine health and sexual well-being applications. Furthermore, the company is involved in the manufacturing, distribution, and sales of general medical apparatus. Sisram Medical's offerings are available under its prominent brand names, which include Alma, Soprano, Harmony, Copulla, Foshion, Accent, and LMNT.
最新データ
HK$1.99
−HK$0.01 · -0.50%
日中の時刻はHKTです。市場データは遅延する場合があります。
Sisram Medical Ltd, an investment holding company headquartered in Caesarea, Israel, since its establishment in 2013, is engaged in the creation, production, and worldwide distribution of a broad spectrum of medical solutions. The company develops and markets energy-based aesthetic devices, minimally invasive therapeutic systems, non-energy-dependent equipment, and cosmeceuticals, reaching markets across Asia Pacific, Europe, North America, Latin America, the Middle East, and Africa. Its comprehensive range of products and treatments addresses numerous conditions, such as hair removal, skin revitalization, acne and scarring, body and facial sculpting, pigment and skin surface refinement, fat transfer procedures, injectable dermal fillers, skin tissue regeneration injectables, personal wellness items, cosmetic dental procedures, transdermal delivery methods, cellulite reduction, stretch mark amelioration, therapy for vascular and pigmented lesions, hydradermabrasion, non-surgical eyelid lifts (blepharoplasty), liposuction, as well as feminine health and sexual well-being applications. Furthermore, the company is involved in the manufacturing, distribution, and sales of general medical apparatus. Sisram Medical's offerings are available under its prominent brand names, which include Alma, Soprano, Harmony, Copulla, Foshion, Accent, and LMNT.
日中レンジ
現在 HK$1.99
52週レンジ
現在 HK$1.99
日中の時刻はHKTです。市場データは遅延する場合があります。
Sisram Medical Ltd, an investment holding company headquartered in Caesarea, Israel, since its establishment in 2013, is engaged in the creation, production, and worldwide distribution of a broad spectrum of medical solutions. The company develops and markets energy-based aesthetic devices, minimally invasive therapeutic systems, non-energy-dependent equipment, and cosmeceuticals, reaching markets across Asia Pacific, Europe, North America, Latin America, the Middle East, and Africa. Its comprehensive range of products and treatments addresses numerous conditions, such as hair removal, skin revitalization, acne and scarring, body and facial sculpting, pigment and skin surface refinement, fat transfer procedures, injectable dermal fillers, skin tissue regeneration injectables, personal wellness items, cosmetic dental procedures, transdermal delivery methods, cellulite reduction, stretch mark amelioration, therapy for vascular and pigmented lesions, hydradermabrasion, non-surgical eyelid lifts (blepharoplasty), liposuction, as well as feminine health and sexual well-being applications. Furthermore, the company is involved in the manufacturing, distribution, and sales of general medical apparatus. Sisram Medical's offerings are available under its prominent brand names, which include Alma, Soprano, Harmony, Copulla, Foshion, Accent, and LMNT.
日中レンジ
現在 HK$1.99
52週レンジ
現在 HK$1.99
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標(USD) | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 3.65億 USD | 3.49億 USD | 3.59億 USD | 3.54億 USD | 2.94億 USD |
| 売上原価 | 1.5億 USD | 1.32億 USD | 1.4億 USD | 1.52億 USD | 1.27億 USD |
| 粗利益 | 2.15億 USD | 2.17億 USD | 2.2億 USD | 2.02億 USD | 1.67億 USD |
| 研究開発 | 1686.1万 USD | 1593.7万 USD | 1802.9万 USD | 1802.3万 USD | 1559.4万 USD |
| 販売・一般管理 | 1.66億 USD | 1.65億 USD | 1.59億 USD | 1.29億 USD | 1.01億 USD |
| 営業費用 | 1.83億 USD | 1.81億 USD | 1.77億 USD | 1.47億 USD | 1.16億 USD |
| 受取利息 | 96.24万 USD | 79万 USD | 22.2万 USD | 61.3万 USD | 54.3万 USD |
| 支払利息 | 324.98万 USD | 245.5万 USD | 206.4万 USD | 197.2万 USD | 200.5万 USD |
| 減価償却費と償却費 | 1734.9万 USD | 1730.6万 USD | 1423.5万 USD | 1240.2万 USD | 1228.5万 USD |
| 営業利益 | 3255.5万 USD | 3565.7万 USD | 4205.9万 USD | 5544.4万 USD | 5055.9万 USD |
| 純利益 | 1901.6万 USD | 2512.6万 USD | 3149.9万 USD | 4017万 USD | 3124.5万 USD |
会社概要が更新されました 2026年10月14日.
直近の発表実績
直近の発表実績
この株式へのエクスポージャーを報告している上場投資信託です。
WisdomTree International SmallCap Dividend FundDLS18.55万0.02%10.37億 USD0.58%$86.365+0.60%
WisdomTree Dynamic International SmallCap Equity ETFDDLS7.33万0.02%4.15億 USD0.48%$44.84+0.16%
WisdomTree Dynamic International Equity FundDDWM4.1万0.00%14.12億 USD0.40%$45.64+0.46%
Avantis International Small Cap Value ETFAVDV4831.37—199.2億 USD0.36%$108.58+0.51%
WisdomTree International SmallCap Dividend FundDLS
WisdomTree Dynamic International SmallCap Equity ETFDDLS
WisdomTree Dynamic International Equity FundDDWM
Avantis International Small Cap Value ETFAVDVAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。